1Pacini F, Elisei R, Capezzone, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low and hi risk patients [ J ]. Thyroid,2001,11 ( 9 ) :877 - 881.
6Maxon HR, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer [J]. Endocrinol Metab Clin North Am, 1990,19(7) :685 ～ 718.
7Pacini F, Pinchera A, Giani C, et al. Serum thyroglobulin concentration and 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyoidectomy) [J]. Clin Endocrinol, 1980,13(2):107 ～ 110.
8陈盛祖.临床技术操作规范(核医学分册)[M].北京:人民军医出版社,2004.179.
9Paul WL, Marjorie E, Richard AD. Practical application of recombinant thyrotropin testing in clinical practice [J]. Endocrine Practice, 2001,7(2): 195 ～ 201.
10Baskin HJ, Atwood TM, Holcomb LP. Recombinant human thyroglobulin in the follow-up of patients with stage Ⅰ or Ⅱ differentiated thyroid carcinoma [J]. Endocrine Practice, 2000,6(5) :430 ～ 434.
7BurgessJR,TuckerP.Incidence trends for papilary thyroid carcinoma and their correlation with thyroid fine-needle aspirate cytology[J].Thyroid,2006,16(1):47.
8Davies L,Welch HG.Increasing incidence of thyroid cancer in the United States,1973-2002[J].Jama,2006,295(18):2164.
9Harness JK,Van Heerden JA,Lennquist S,Rothmund M,Barraclough BH,Goode AW,Rosen IB,Fujimoto Y,Proye C.Future of thyroid surgery and training surgeons to meet the expectations of 2000 and beyond[J].World Journal Surgery,2000,24(8):976.
10Haigh PI,Urbach DR,Rostein LE.Extent of thyroidectomy is not a maior determinant of survival in low or high risk papillary thyroid cancer[J].Ann Surg Oncol,2005,12(1):81.
